New ICD-10 Code Supports AI Sepsis Diagnostic Tools
The Centers for Medicare & Medicaid Services (CMS) has introduced a new ICD-10-PCS code to support AI sepsis diagnostic technologies, including Prenosis' Sepsis ImmunoScore, announced in a press release. Effective October 1, 2025, hospitals can utilize the code XXEZXCB to document the clinical use of these technologies.
This new coding structure marks a significant advancement in the standardization and recognition of computer-aided sepsis diagnostic tools within the healthcare system. It facilitates accurate documentation and tracking of Sepsis ImmunoScore's implementation, which is crucial for clinical quality measurement and reimbursement optimization.
The establishment of this specific code also serves as a prerequisite for New Technology Add-on Payment (NTAP) submission processes, enabling healthcare organizations to integrate Sepsis ImmunoScore into their documentation workflows seamlessly. This development highlights the healthcare industry's commitment to adopting evidence-based diagnostic innovations that enhance sepsis detection and patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell Images Sep 29 Axxess Partners With Eazewell for Hospice Family SupportLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
EpiVax Adds AI Models to ISPRI Immunogenicity Platform
CluePoints Releases Three AI Tools for Clinical Data Review
Blue Cross Analysis Links Hospital AI to $942 Million in Added Costs
XpertDox Brings AI Medical Coding to Kai Shin Clinic
Aignostics Opens Early Access to PathoSearch
Daily AI Brief: the AI news that matters, in your inbox.